ESC Premium Access

Lp(a): should we go after it? Should it modify our lipid targets?

Topic: Lipids (Epidemiology and Prevention)

Congress Presentation

About the speaker

Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)
17 presentations
0 follower

4 more presentations in this session

SPRINT and HOPE3: implications for the treatment of hypertension.

Speaker: Doctor S. Yusuf (Hamilton, CA)


How much exercise is needed to prevent heart disease?

Speaker: Doctor C. Lavie (New Orleans, US)


"Statins for life"? The effect of statins on survival in primary prevention.

Speaker: Professor P. Greenland (Chicago, US)


"Plaque but no obstructive coronary disease" - Primary or secondary prevention?

Speaker: Professor S. Halvorsen (Oslo, NO)


Access the full session

The Primary Prevention Summit

Speakers: Professor J. Chapman, Doctor S. Yusuf, Doctor C. Lavie, Professor P. Greenland, Professor S. Halvorsen

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb